• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑屏障保护作为急性缺血性脑卒中的治疗策略。

Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 S. Coulter, Amarillo, Texas, 79106, USA.

出版信息

AAPS J. 2017 Jul;19(4):957-972. doi: 10.1208/s12248-017-0091-7. Epub 2017 May 8.

DOI:10.1208/s12248-017-0091-7
PMID:28484963
Abstract

The blood-brain barrier (BBB) is a vital component of the neurovascular unit (NVU) containing tight junctional (TJ) proteins and different ion and nutrient transporters which maintain normal brain physiology. BBB disruption is a major pathological hallmark in the course of ischemic stroke which is regulated by the actions of different factors working at different stages of cerebral ischemia including matrix metalloproteinases (MMPs), inflammatory modulators, vesicular trafficking, oxidative pathways, and junctional-cytoskeletal interactions. These components interact further to disrupt maintenance of both the paracellular and transport barriers of the central nervous system (CNS) to worsen ischemic brain injury and the propensity for hemorrhagic transformation (HT) associated with injury and/or thrombolytic therapy with tissue-type plasminogen activator (tPA). We propose that these complex molecular pathways should be evaluated further so that they could be targeted alone or in combination to protect the BBB during cerebral ischemia. These types of novel interventions should be guided by advanced imaging techniques for better diagnosis of BBB damage which may exert significant therapeutic benefit including the extension of therapeutic window of tPA. This review will focus on the different stages and mechanisms of BBB damage in acute ischemic stroke and novel therapeutic strategies to target those pathways for better therapeutic outcome in stroke.

摘要

血脑屏障(BBB)是神经血管单元(NVU)的重要组成部分,包含紧密连接(TJ)蛋白和不同的离子和营养转运体,它们维持着正常的大脑生理学。BBB 破坏是缺血性中风过程中的主要病理标志,受不同因素在脑缺血不同阶段的作用调节,包括基质金属蛋白酶(MMPs)、炎症调节剂、囊泡转运、氧化途径和连接细胞骨架相互作用。这些成分进一步相互作用,破坏中枢神经系统(CNS)的细胞旁和转运屏障的维持,导致缺血性脑损伤恶化,并增加与损伤和/或组织型纤溶酶原激活物(tPA)溶栓治疗相关的出血性转化(HT)的倾向。我们提出,应该进一步评估这些复杂的分子途径,以便单独或联合靶向这些途径,在脑缺血期间保护 BBB。这些新型干预措施应该由先进的成像技术指导,以便更好地诊断 BBB 损伤,这可能会产生显著的治疗益处,包括延长 tPA 的治疗窗口。本综述将重点介绍急性缺血性中风中 BBB 损伤的不同阶段和机制,以及针对这些途径的新型治疗策略,以获得更好的中风治疗效果。

相似文献

1
Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.血脑屏障保护作为急性缺血性脑卒中的治疗策略。
AAPS J. 2017 Jul;19(4):957-972. doi: 10.1208/s12248-017-0091-7. Epub 2017 May 8.
2
Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.常压高氧可减缓血脑屏障损伤,并扩大组织型纤溶酶原激活剂治疗脑缺血的治疗时间窗。
Stroke. 2015 May;46(5):1344-1351. doi: 10.1161/STROKEAHA.114.008599. Epub 2015 Mar 24.
3
New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.急性缺血性脑卒中血脑屏障保护方法的新进展。
Brain Res Bull. 2019 Jan;144:46-57. doi: 10.1016/j.brainresbull.2018.11.006. Epub 2018 Nov 15.
4
Blood-brain barrier dysfunction and recovery after ischemic stroke.缺血性脑卒中后血脑屏障功能障碍与修复。
Prog Neurobiol. 2018 Apr-May;163-164:144-171. doi: 10.1016/j.pneurobio.2017.10.001. Epub 2017 Oct 5.
5
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.缺血性脑卒中血脑屏障损伤的神经炎症机制。
Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135-C153. doi: 10.1152/ajpcell.00136.2018. Epub 2018 Oct 31.
6
Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.分子机制与血脑屏障在缺血性脑卒中损伤中的研究进展:基质金属蛋白酶和组织型纤溶酶原激活物的关键作用
Neurobiol Dis. 2010 Jun;38(3):376-85. doi: 10.1016/j.nbd.2010.03.008. Epub 2010 Mar 17.
7
Therapeutic approaches to vascular protection in ischemic stroke.缺血性卒中血管保护的治疗方法。
Acta Med Okayama. 2011 Aug;65(4):219-23. doi: 10.18926/AMO/46846.
8
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.缺血性脑卒中的血脑屏障功能障碍:针对紧密连接和转运体的血管保护作用。
Am J Physiol Cell Physiol. 2018 Sep 1;315(3):C343-C356. doi: 10.1152/ajpcell.00095.2018. Epub 2018 Jun 27.
9
Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis?早期缺血性血脑屏障损伤:组织型纤溶酶原激活剂(tPA)溶栓后出血转化的潜在指标?
Curr Neurovasc Res. 2014;11(3):254-62. doi: 10.2174/1567202611666140530145643.
10
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.重组组织型纤溶酶原激活剂在短暂性局灶性脑缺血后通过基质金属蛋白酶-9 非依赖性途径诱导血脑屏障破裂。
Eur J Neurosci. 2011 Oct;34(7):1085-92. doi: 10.1111/j.1460-9568.2011.07843.x. Epub 2011 Sep 6.

引用本文的文献

1
,-dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation.N,N-二甲基色胺通过稳定血脑屏障和减轻神经炎症来减轻实验性中风。
Sci Adv. 2025 Aug 15;11(33):eadx5958. doi: 10.1126/sciadv.adx5958. Epub 2025 Aug 13.
2
Acupuncture Alleviates Blood-Brain Barrier Damage After Delayed rtPA Thrombolysis for Acute Ischemic Stroke by Regulating Ferroptosis.针刺通过调节铁死亡减轻急性缺血性卒中延迟rtPA溶栓后的血脑屏障损伤。
Brain Behav. 2025 Jul;15(7):e70644. doi: 10.1002/brb3.70644.
3
(L.) Extract PAS840 Promotes Ischemic Stroke Recovery by Inhibiting Inflammasome Activation.

本文引用的文献

1
Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat.含有环孢素A的纳米脂质体可减轻大鼠脑缺血/再灌注中的神经炎症反应并改善神经活动。
Fundam Clin Pharmacol. 2017 Apr;31(2):185-193. doi: 10.1111/fcp.12244. Epub 2016 Oct 28.
2
Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia.钠通过脑钠-葡萄糖转运体的转运在脑缺血期间会加剧神经元损伤。
J Pharm Pharmacol. 2016 Jul;68(7):922-31. doi: 10.1111/jphp.12571. Epub 2016 May 3.
3
Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil.
(左)PAS840提取物通过抑制炎性小体激活促进缺血性中风恢复。
Biology (Basel). 2025 May 22;14(6):589. doi: 10.3390/biology14060589.
4
Biomarkers of blood-brain barrier and neurovascular unit integrity in human cognitive impairment and dementia.人类认知障碍和痴呆症中血脑屏障及神经血管单元完整性的生物标志物
Alzheimers Dement. 2025 Mar;21(3):e70104. doi: 10.1002/alz.70104.
5
Post-stroke depression: exploring gut microbiota-mediated barrier dysfunction through immune regulation.中风后抑郁症:通过免疫调节探索肠道微生物群介导的屏障功能障碍
Front Immunol. 2025 Mar 3;16:1547365. doi: 10.3389/fimmu.2025.1547365. eCollection 2025.
6
Effect and mechanism of Dichloroacetate in the treatment of stroke and the resolution strategy for side effect.二氯乙酸治疗中风的作用、机制及副作用的解决策略
Eur J Med Res. 2025 Mar 3;30(1):148. doi: 10.1186/s40001-025-02399-5.
7
Blood-Brain Barrier Disruption and Imaging Assessment in Stroke.中风中的血脑屏障破坏与影像学评估
Transl Stroke Res. 2024 Sep 25. doi: 10.1007/s12975-024-01300-6.
8
Sigma-1 receptor signaling: A potential therapeutic approach for ischemic stroke.西格玛-1受体信号传导:缺血性中风的一种潜在治疗方法。
J Cereb Blood Flow Metab. 2024 Dec;44(12):1430-1440. doi: 10.1177/0271678X241281547. Epub 2024 Sep 9.
9
Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction.纳米技术增强型纳洛酮及阿片类药物成瘾的替代疗法
ACS Pharmacol Transl Sci. 2024 May 27;7(8):2237-2250. doi: 10.1021/acsptsci.4c00158. eCollection 2024 Aug 9.
10
Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis.变革中风护理:基于纳米技术的脑递送作为治疗和诊断的新范式
Mol Neurobiol. 2025 Jan;62(1):184-220. doi: 10.1007/s12035-024-04215-3. Epub 2024 Jun 3.
脂质体法舒地尔静脉给药对脑缺血/再灌注损伤的神经保护作用。
Int J Pharm. 2016 Jun 15;506(1-2):129-37. doi: 10.1016/j.ijpharm.2016.04.046. Epub 2016 Apr 20.
4
The blood-brain barrier after stroke: Structural studies and the role of transcytotic vesicles.中风后的血脑屏障:结构研究及转胞吞小泡的作用
J Cereb Blood Flow Metab. 2017 Feb;37(2):456-470. doi: 10.1177/0271678X16629976. Epub 2016 Jul 21.
5
Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury.快速的内皮细胞骨架重组可导致早期血脑屏障破坏和长期缺血再灌注脑损伤。
Nat Commun. 2016 Jan 27;7:10523. doi: 10.1038/ncomms10523.
6
Translational Stroke Research on Blood-Brain Barrier Damage: Challenges, Perspectives, and Goals.血脑屏障损伤的转化性卒中研究:挑战、前景与目标
Transl Stroke Res. 2016 Apr;7(2):89-92. doi: 10.1007/s12975-016-0447-9. Epub 2016 Jan 13.
7
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
8
Mechanisms Underlying Astrocyte Endfeet Swelling in Stroke.中风中星形胶质细胞终足肿胀的潜在机制。
Acta Neurochir Suppl. 2016;121:19-22. doi: 10.1007/978-3-319-18497-5_4.
9
Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.T7共轭聚乙二醇化脂质体药物递送系统增强ZL006对缺血性中风的治疗作用
Sci Rep. 2015 Jul 29;5:12651. doi: 10.1038/srep12651.
10
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.2015年美国心脏协会/美国卒中协会对2013年急性缺血性卒中患者早期管理指南中血管内治疗部分的重点更新:美国心脏协会/美国卒中协会给医疗专业人员的指南
Stroke. 2015 Oct;46(10):3020-35. doi: 10.1161/STR.0000000000000074. Epub 2015 Jun 29.